Home › Funds › Tejara Capital Ltd › SPRY

Tejara Capital Ltd position in SPRY

ARS PHARMACEUTICALS INC · Health Care

Tejara Capital Ltd reported holding 589,042 shares of SPRY (ARS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 1.24% of its reported portfolio and ranking #20 among its reported holdings. Tejara Capital Ltd has disclosed SPRY holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)589.04K sh
Reported value held$2.54M
Portfolio Weight1.24%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tejara Capital Ltd's SPRY position evolved

Tejara Capital Ltd first disclosed a stake in SPRY in Q3 2023 at 103,739 shares (US$392K). The position peaked in Q2 2026 at 607,039 shares, worth US$4.9M. Across 5 filings, Tejara Capital Ltd increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 589,042 shares valued at US$2.5M — a reduction of -17,997 shares quarter over quarter.. Notable position changes include a 29% trim in Q4 2023 (shares rose 86% over the following quarter), a 189% increase in Q2 2026 (shares fell 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 103.74K $392.13K New
Q4 2023 73.74K $404.09K Reduce
Q1 2026 210.40K $1.69M New
Q2 2026 607.04K $4.86M Add
Q3 2026 589.04K $2.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPRY and 13F data

SPRY (ARS PHARMACEUTICALS INC) is a Health Care company. 21 other funds we track also report a position in SPRY — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$87.0M), Rubric Capital Management LP (US$68.4M), ORBIMED ADVISORS LLC (US$66.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPRY

All SPRY fund holders →

FAQ

How long has Tejara Capital Ltd held SPRY?

Tejara Capital Ltd has disclosed SPRY holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

What is Tejara Capital Ltd's current position in SPRY?

As of Q3 2026, Tejara Capital Ltd holds 589.04K shares of SPRY (ARS PHARMACEUTICALS INC), valued at $2.54M, representing 1.24% of its reported portfolio and ranking #20.

Has Tejara Capital Ltd been buying or selling SPRY?

In the latest 13F filing (Q3 2026), Tejara Capital Ltd reduced its position in SPRY. The position peaked in Q2 2026 at 607.04K shares.

Which other funds hold SPRY?

Other major institutional holders of SPRY include RA CAPITAL MANAGEMENT, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.